This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Fragment-Based Drug Discovery
From Proteopedia
(Difference between revisions)
| Line 11: | Line 11: | ||
| - | <scene name='Sandbox_reserved_394/Bcl-xl/1'>Bcl-xl</scene> is a member of the Bcl-2 family. The protein | + | <scene name='Sandbox_reserved_394/Bcl-xl/1'>Bcl-xl</scene> is a member of the Bcl-2 family. The protein is comprised of seven <scene name='Sandbox_reserved_394/Alpha_helices/1'>alpha helices</scene>, no beta sheets, and 221 amino acid residues. |
==== Bcl-xl Inhibition ==== | ==== Bcl-xl Inhibition ==== | ||
Revision as of 01:20, 3 October 2012
Apoptosis by Inhibition of Bcl-2 Family Proteins
| |||||||||||
References
- ↑ Oltersdorf T., Elmore S.W., Shoemaker A.R. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Vol 435|2 June 2005|doi:10.1038/nature03579
